TTTY9B

Across TCGA pan-cancer cohorts, TTTY9B mass-spec protein is linked to patient survival in 3 of 34 cancer types, making it a survival-associated TTTY9B data layer compared with 6 for mass-spec protein.

The strongest signal is observed in pancreatic ductal adenocarcinoma (PDAC), where higher TTTY9B mass-spec protein is associated with worse overall survival. In most high-consensus cancer types, elevated TTTY9B expression acts as an unfavorable survival marker.

PDAC, LUAD, and HNSC are the cancer types where TTTY9B mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
PDAC	OS	Quartile	All	0.804	0.932	.010	11	view →
LUAD	DFS	Median	II,III,IV	0.846	1.000	.044	4	view →
HNSC	DFS	Median	III,IV	0.696	0.848	.049	1	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

TTTY9B–PDAC (OS)

Open the PDAC breakdown →